About Amneal Oncology Private Limited
Data last updated:
Amneal Oncology Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Amneal Pharmaceuticals Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 10 November 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1998PTC084755. Its GSTIN is 24AAACE9129K1ZJ (Gujarat). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹35 Cr and a paid-up capital of ₹33.65 Cr. It was formerly known as Epsilon Pharmaceuticals Private Limited. It is led by directors including Rajeev Midha and Suresh Punambhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 901 – 911 Iscon Elegance Opp. Karnavati Club S.G.Highway, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹144.26 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹14.82 Cr (net margin 10.3%) and EBITDA of ₹32.37 Cr (EBITDA margin 22.4%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 15% over five years.
The company has about 262 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹58.32 Cr on record. Court records list 7 cases involving the company, including 6 filed by the company and 1 filed against it; 4 cases are pending. The company has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹104.62 Cr; the latest was in December 2014. Its 4 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 3 larger and 1 smaller; the largest is Jamp India Pharmaceuticals Private Limited with revenue of ₹155.09 Cr. The company has 15 MSME Form 1 returns on record between 2018 and 2023, listing 280 overdue payments to 35 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amneal.com.
Company details
CIN history
Amneal Oncology has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230GJ1998PTC084755, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ1998PTC084755 | Current |
| U24230AP1998PTC030477 | Previous |
| U24230TG1998PTC030477 | Previous |
Contact details
Amneal Oncology Private Limited's registered office is in Ahmedabad, Gujarat. Its website is amneal.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address901 – 911 Iscon Elegance Opp. Karnavati Club S.G.Highway, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Amneal Oncology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Amneal Oncology are professional, scientific and technical and manufacturing. In detail, this covers scientific research and development and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Amneal Oncology Private Limited, buy the company report.
Financials of Amneal Oncology Private Limited
FY 2024 filings availableAmneal Oncology Private Limited reported revenue of ₹144.26 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 19% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32.37 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.82 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.4% | ||||
| Net Profit Margin | 10.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amneal Oncology Private Limited, buy the company report.
Board of directors of Amneal Oncology Private Limited
Amneal Oncology has 4 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Midha Also directs: Amneal Pharmaceuticals Private Limited, Raks Pharma Private Limited, Amneal Healthcare Private Limited and 2 more | Director | 25 Jan 2019 | 7 Years 9 Months | Current |
| Suresh Punambhai Patel Also directs: Kayura Effect LLP, Shivanka Research Private Limited, Amneal Pharmaceuticals Private Limited and 5 more | Director | 01 Dec 2014 | 11 Years 10 Months | Current |
| Rahul Maitra Also directs: Amneal Pharmaceuticals Private Limited, Raks Pharma Private Limited, Amneal Healthcare Private Limited and 3 more | Director | 14 May 2024 | 2 Years 5 Months | Current |
| Sandeep Radhakisan Raktate Also directs: Amneal Pharmaceuticals Private Limited, Raks Pharma Private Limited, Amneal Healthcare Private Limited and 3 more | Director | 14 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Amneal Oncology Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jamp India Pharmaceuticals Private Limited | ₹155.09 Cr (FY 2025) | 19.0% | Ahmedabad, Gujarat, India | |||
| Raptim Research Private Limited | ₹146.15 Cr (FY 2025) | -4.0% | Navi Mumbai, Maharashtra, India | |||
| Synzeal Research Private Limited | ₹144.48 Cr (FY 2025) | 19.0% | Bavla, Gujarat, India | |||
| Amneal Oncology Private Limitedthis company | ₹144.26 Cr (FY 2025) | ₹14.82 Cr | 10.3% | 19.0% | 262 | Ahmedabad, Gujarat, India |
| Navitas Life Sciences Private Limited | ₹125.66 Cr (FY 2025) | -4.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Amneal Oncology Private Limited, buy the company report.
Auditor
Amneal Oncology Private Limited is audited by Chandulal M. Shah & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chandulal M. Shah & Co. | FY 2023 | 101698W |
Shareholding
The shareholding of Amneal Oncology Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Amneal Oncology Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Dec 2011 | 10324740 | Vijaya Bank (Lead Bank) | ₹58.21 Cr | Satisfied | |
| 24 Feb 2011 | 10269972 | Vijaya Bank | ₹10.9 Lakh | Satisfied |
To see the full charge records of Amneal Oncology Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Amneal Oncology Private Limited has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹104.62 Cr; the latest was in December 2014.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2014 | Funding round | ₹84.64 Cr | Investors: Amneal Pharmaceuticals Private Limited |
| Dec 2014 | Secondary share transfer | Undisclosed | Buyer: Amneal Pharmaceuticals Private Limited Seller: Jivanta Laboratories Limited, Chillakuru Investments Pvt Ltd , 2 individuals |
| Apr 2014 | Secondary share transfer | Undisclosed | Buyer: Amneal Pharmaceuticals Private Limited Seller: Deepaditya Developers Limited |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Jivanta Laboratories Limited, Deepaditya Developers Limited , an individual |
| Apr 2013 | Funding round | ₹18 Cr | Investors: Jivanta Laboratories Limited, Chillakuru Investments Pvt Ltd , Deepaditya Developers Limited , an individual |
To see the full deal history of Amneal Oncology Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Amneal Oncology Private Limited has 7 court cases on record: 6 filed by Amneal Oncology, 1 filed against it. 4 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 0 | 4 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by Osi Consulting Pvt Ltd | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against The Assistant Commissioner (St) and 3 others | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against The Assistant Commissioner (St) and 3 Others and 3 others | Pending |
| High Court | Writ petition | Filed by the company against The State of Telangana, Rep. by Its Principal Secretary, and 2 others | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against The State of Telangana and 2 Others and 2 others | Disposed |
To see the full case history of Amneal Oncology Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Amneal Oncology Private Limited has 15 MSME Form 1 returns on record between 2018 and 2023, listing 280 overdue payments to 35 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 35)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| A P Securitas Private Limited | |||
| an individual supplier | |||
| DD Enterprises | |||
| an individual supplier |
To see the full MSME payment records of Amneal Oncology Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Amneal Oncology Private Limited has a workforce of 262 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Amneal Oncology has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACE9129K1ZJ | Gujarat | Active | 30 Sep 2021 |
| 36AAACE9129K2ZD | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Amneal Oncology Private Limited, buy the company report.
Recent activity
Amneal Oncology Private Limited has 16 board changes on record since 2012: 4 appointments and 12 cessations. The latest: Rahul Maitra ceased to be Additional Director on 29 Sep 2024.
12 earlier events are in the company report.
News
Frequently asked questions
Amneal Oncology is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 10 November 1998 (28+ years old) and is registered under CIN U24230GJ1998PTC084755.
Amneal Oncology has 4 current directors:
- Rajeev Midha - Director
- Suresh Punambhai Patel - Director
- Rahul Maitra - Director
- Sandeep Radhakisan Raktate - Director
The latest financial statements of Amneal Oncology on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Amneal Oncology is 24AAACE9129K1ZJ, registered in Gujarat. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 36AAACE9129K2ZD (Telangana).
The CIN (Corporate Identification Number) of Amneal Oncology is U24230GJ1998PTC084755. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amneal Oncology has 7 court cases on record: 6 filed by the company and 1 filed against it. 4 are pending. Most are in the high courts.
Amneal Oncology was incorporated on 10 November 1998, making it 28+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Amneal Oncology has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹104.62 Cr; the latest was in December 2014.
The peers of Amneal Oncology by revenue are Jamp India Pharmaceuticals Private Limited, Raptim Research Private Limited, Synzeal Research Private Limited, Navitas Life Sciences Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Rahul Maitra ceased to be Additional Director on 29 Sep 2024. Sandeep Radhakisan Raktate ceased to be Additional Director on 29 Sep 2024. Rahul Maitra was appointed as Director on 14 May 2024. Amneal Oncology has 16 board changes on record in total.
Amneal Oncology has 15 MSME Form 1 returns on record between 2018 and 2023, listing 280 overdue payments to 35 micro and small suppliers. The latest return was filed on 18 Dec 2023.
Amneal Oncology can be reached through the website amneal.com. Its registered office is in Ahmedabad, Gujarat, India.